[1]
Gozzi, P.T. et al. 2022. ELABORATION OF GUIDELINE FOR MONITORING IN RELATIVE BIOAVAILABILITY / PHARMACEUTICAL BIOEQUIVALENCE STUDY BY THE SPONSOR. Arquivos de Ciências da Saúde da UNIPAR. 26, 3 (set. 2022). DOI:https://doi.org/10.25110/arqsaude.v26i3.2022.8400.